FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness

Elisa Canepa, Rebecca Parodi-Rullan, Rafael Vazquez-Torres, Begona Gamallo-Lana, Roberto Guzman-Hernandez, Nicole L Lemon, Federica Angiulli, Ludovic Debure, Marc A Ilies, Leif Østergaard, Thomas Wisniewski, Eugenio Gutiérrez-Jiménez, Adam C Mar, Silvia Fossati*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Fingeraftryk

Dyk ned i forskningsemnerne om 'FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness'. Sammen danner de et unikt fingeraftryk.

Medicine and Dentistry

Neuroscience